In June 2020, Innovate UK’s CEO Ian Campbell confirmed that the Biomedical Catalyst was to be relaunched, allowing innovative biotech companies to access a share of £30 million in grant funding.

Key points:

  • This is an Innovate UK competition for projects led by SMEs or RTOs
  • Opens 27th July
  • Submissions by 7th October
  • Up to £30M available
  • SMEs can apply for grants for £250k to £4M total project costs


The aim of this competition is to enable companies to create a data package that can support the subsequent testing of their products or carry out evaluations in a clinical setting or other relevant environment. This can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • demonstrating of clinical utility and effectiveness
  • demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Project must focus on the development of a product or process that is an innovative solution to a defined health and care challenge.

Enquiries to